Video

Q&A With Craig Strasnick From Commonwealth Laboratories: New Test Looks for Fast Identification of Irritable Bowel Syndrome

Author(s):

Whether patients have irritable bowel syndrome or inflammatory bowel disease what matters to them most is getting the correct diagnosis and treatment as quickly as possible.

Whether patients have irritable bowel syndrome or inflammatory bowel disease what matters to them most is getting the correct diagnosis and treatment as quickly as possible.

Craig Strasnick, Chief Operating Officer of Commonwealth Laboratories discussed IBS Check, a new method for diagnosing the condition and separating the two possible diagnoses in an effort to give patients the best results. Strasnick said an "exclusionary pathway" has been used in the past which can often require medical procedures and can take longer before getting the final and correct diagnosis.

Related Videos
Jörn Schattenberg, MD | Credit: Novo Nordisk
Jörn Schattenberg, MD | Credit: Novo Nordisk
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
AMG0001 Advances Healing in CLTI with David G. Armstrong, DPM, PhD, and Michael S. Conte, MD | Image Credit: Canva
Malin Fromme, MD | Credit: RWTH Aachen
Pavel Strnad, MD | Credit: AASLD
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Gideon Hirschfield, FRCP, PhD | Credit: UHN Foundation
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
© 2024 MJH Life Sciences

All rights reserved.